LOS ANGELES, Aug. 8, 2024 /PRNewswire/ — Global Bridge Associates (GBA), a leading study abroad and homestay organization, is excited to announce significant business growth and the launch of its newly redesigned website. This expansion reflects GBA’s commitment to enhancing international education experiences and providing exceptional, personalized support to exchange students and host families worldwide. […]
Category Archives: Pr Newswire
PARIS, Aug. 8, 2024 /PRNewswire/ — Hou Zhihui, representing the Chinese national team and the Hunan Zoomlion Weightlifting Team, achieved a stunning victory in the women’s 49kg weightlifting category at the Paris Olympics. Despite trailing in the snatch and facing a win-or-bust moment in her final clean and jerk attempt, Hou made an incredible comeback […]
SINGAPORE, Aug. 8, 2024 /PRNewswire/ — Trinasolar, a global leader in smart PV and energy storage solutions has entered into a research collaboration with the Agency for Science, Technology and Research (A*STAR) Singapore’s lead public sector R&D agency. This collaboration aims to advance the optimization and upgrading of industrial battery manufacturing technologies, contributing to the green and […]
Exicom to acquire business and assets of Tritium, a distinguished global leader in DC Fast Chargers, headquartered in Australia Acquisition seen as an ideal anchor towards building a global EV charger business with Tritium’s presence in 47 countries Exicom will have access to Tritium’s cutting-edge manufacturing facility in Tennessee, USA, as well as a world-class […]
SHANGHAI, Aug. 8, 2024 /PRNewswire/ — ZKH Group Limited (“ZKH” or the “Company”) (NYSE: ZKH), a leading maintenance, repair and operations (“MRO”) procurement service platform in China, today announced that it will release its unaudited financial results for the second quarter of 2024, on Thursday, August 22, 2024, before the open of the U.S. markets. […]
Pr Newswire
Novartis receives FDA accelerated approval for Fabhalta® (iptacopan), the first and only complement inhibitor for the reduction of proteinuria in primary IgA nephropathy (IgAN)
08
Aug
Aug
Ad hoc announcement pursuant to Art. 53 LR Fabhalta achieved a 44% proteinuria reduction from baseline in Phase III APPLAUSE-IgAN interim analysis, compared with 9% in placebo arm, demonstrating a clinically meaningful reduction of 38% vs. placebo (p<0.0001)1 Fabhalta is an inhibitor of the alternative complement pathway, activation of which is thought to contribute to the pathogenesis of […]
08
Aug
Aug
HOUSTON, Aug. 07, 2024 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 150+ patents issued and pending for the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, has filed its Quarterly Report on Form 10-Q for the quarter ended June 30, 2024, with the […]
08
Aug
Aug
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Aug. 07, 2024 (GLOBE NEWSWIRE) — Centogene N.V., the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced that it received a notice from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Nasdaq Hearings Panel has determined to delist CENTOGENE’S common stock […]
Pr Newswire
ProSomnus® Sleep Technologies Announces Record Revenues as it Emerges from Reorganization
08
Aug
Aug
PLEASANTON, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) — ProSomnus Sleep Technologies (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced record revenues for the quarter ended June 30, 2024 as it formally emerges from reorganization on August 5, 2024. Revenues for the second quarter totaled a record $9.1 million reflecting increasing orders for […]
Pr Newswire
Eyenovia and Formosa Pharmaceuticals Initiate Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S.
08
Aug
Aug
Product-candidate would incorporate new steroid with the Optejet® for the millions of dry eye patients who experience periodic flare-ups NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) — Eyenovia, Inc. (NASDAQ: EYEN), a commercial-stage ophthalmic company with two FDA-approved products and a late-stage asset in pediatric progressive myopia, today announced that it has signed a non-binding […]